40 related articles for article (PubMed ID: 17998244)
1. Plasma and serum levels of tissue inhibitor of metalloproteinases-1 are associated with prognosis in node-negative breast cancer: a prospective study.
Würtz SØ; Møller S; Mouridsen H; Hertel PB; Friis E; Brünner N
Mol Cell Proteomics; 2008 Feb; 7(2):424-30. PubMed ID: 17998244
[TBL] [Abstract][Full Text] [Related]
2. TIMP1 shapes an immunosuppressive microenvironment by regulating anoikis to promote the progression of clear cell renal cell carcinoma.
Li Q; Wei K; Zhang X; Lv Y; Li M; Zhou C; Su S; Hou D; Hou J
Aging (Albany NY); 2023 Sep; 15(17):8908-8929. PubMed ID: 37688768
[TBL] [Abstract][Full Text] [Related]
3. Estimation of hub genes and exploration of multi-omics level alterations in the landscape of lung adenocarcinoma.
Li G; Atiq W; Hashmi MF; Ibrahim SS; Al Abdulsalam KA; Kadham MJ; Al-Azzawi AKJ; Aufy M; Abdel-Maksoud MA
Am J Transl Res; 2023; 15(3):1550-1568. PubMed ID: 37056815
[TBL] [Abstract][Full Text] [Related]
4. Myeloma Microenvironmental TIMP1 Induces the Invasive Phenotype in Fibroblasts to Modulate Disease Progression.
Ishihara R; Oda T; Murakami Y; Matsumura I; Watanabe S; Asao Y; Masuda Y; Gotoh N; Kasamatsu T; Takei H; Kobayashi N; Sasaki N; Saitoh T; Murakami H; Handa H
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768545
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases as therapeutic targets in breast cancer.
Kwon MJ
Front Oncol; 2022; 12():1108695. PubMed ID: 36741729
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Tumor Metabolism and Extracellular Acidosis by the TIMP-10-CD63 Axis in Breast Carcinoma.
Najy AJ; Jung YS; Kim S; Fridman R; Kim HC
Cells; 2021 Oct; 10(10):. PubMed ID: 34685701
[TBL] [Abstract][Full Text] [Related]
7. Back to the Future: Rethinking the Great Potential of lncRNA
Elsayed AM; Amero P; Salama SA; Abdelaziz AH; Lopez-Berestein G; Rodriguez-Aguayo C
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32854207
[TBL] [Abstract][Full Text] [Related]
8. TIMP-1 Promotes the Immune Response in Influenza-Induced Acute Lung Injury.
Allen JR; Ge L; Huang Y; Brauer R; Parimon T; Cassel SL; Sutterwala FS; Chen P
Lung; 2018 Dec; 196(6):737-743. PubMed ID: 30167842
[TBL] [Abstract][Full Text] [Related]
9. N-glycan signatures identified in tumor interstitial fluid and serum of breast cancer patients: association with tumor biology and clinical outcome.
Terkelsen T; Haakensen VD; Saldova R; Gromov P; Hansen MK; Stöckmann H; Lingjaerde OC; Børresen-Dale AL; Papaleo E; Helland Å; Rudd PM; Gromova I
Mol Oncol; 2018 Jun; 12(6):972-990. PubMed ID: 29698574
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of TIMP-1 and its cell surface binding partner CD63 in glioblastomas.
Aaberg-Jessen C; Sørensen MD; Matos ALSA; Moreira JM; Brünner N; Knudsen A; Kristensen BW
BMC Cancer; 2018 Mar; 18(1):270. PubMed ID: 29523123
[TBL] [Abstract][Full Text] [Related]
11. Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer.
Prokopchuk O; Grünwald B; Nitsche U; Jäger C; Prokopchuk OL; Schubert EC; Friess H; Martignoni ME; Krüger A
BMC Cancer; 2018 Feb; 18(1):128. PubMed ID: 29394913
[TBL] [Abstract][Full Text] [Related]
12. Profiling of microRNAs in tumor interstitial fluid of breast tumors - a novel resource to identify biomarkers for prognostic classification and detection of cancer.
Halvorsen AR; Helland Å; Gromov P; Wielenga VT; Talman MM; Brunner N; Sandhu V; Børresen-Dale AL; Gromova I; Haakensen VD
Mol Oncol; 2017 Feb; 11(2):220-234. PubMed ID: 28145100
[TBL] [Abstract][Full Text] [Related]
13. Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics.
Espinoza JA; Jabeen S; Batra R; Papaleo E; Haakensen V; Timmermans Wielenga V; Møller Talman ML; Brunner N; Børresen-Dale AL; Gromov P; Helland Å; Kristensen VN; Gromova I
Oncoimmunology; 2016; 5(12):e1248015. PubMed ID: 28123884
[TBL] [Abstract][Full Text] [Related]
14. TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway.
Song G; Xu S; Zhang H; Wang Y; Xiao C; Jiang T; Wu L; Zhang T; Sun X; Zhong L; Zhou C; Wang Z; Peng Z; Chen J; Wang X
J Exp Clin Cancer Res; 2016 Sep; 35(1):148. PubMed ID: 27644693
[TBL] [Abstract][Full Text] [Related]
15. Premetastatic niche formation in the liver: emerging mechanisms and mouse models.
Krüger A
J Mol Med (Berl); 2015 Nov; 93(11):1193-201. PubMed ID: 26400831
[TBL] [Abstract][Full Text] [Related]
16. Tissue inhibitor of metalloproteinases (TIMP)-1 creates a premetastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice.
Seubert B; Grünwald B; Kobuch J; Cui H; Schelter F; Schaten S; Siveke JT; Lim NH; Nagase H; Simonavicius N; Heikenwalder M; Reinheckel T; Sleeman JP; Janssen KP; Knolle PA; Krüger A
Hepatology; 2015 Jan; 61(1):238-48. PubMed ID: 25131778
[TBL] [Abstract][Full Text] [Related]
17. TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group.
Jørgensen CL; Bjerre C; Ejlertsen B; Bjerre KD; Balslev E; Bartels A; Brünner N; Nielsen DL
BMC Cancer; 2014 May; 14():360. PubMed ID: 24884504
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer: a retrospective study.
Thorsen SB; Christensen SL; Würtz SO; Lundberg M; Nielsen BS; Vinther L; Knowles M; Gee N; Fredriksson S; Møller S; Brünner N; Schrohl AS; Stenvang J
BMC Cancer; 2013 Dec; 13():598. PubMed ID: 24330623
[TBL] [Abstract][Full Text] [Related]
19. Detection of serological biomarkers by proximity extension assay for detection of colorectal neoplasias in symptomatic individuals.
Thorsen SB; Lundberg M; Villablanca A; Christensen SL; Belling KC; Nielsen BS; Knowles M; Gee N; Nielsen HJ; Brünner N; Christensen IJ; Fredriksson S; Stenvang J; Assarsson E
J Transl Med; 2013 Oct; 11():253. PubMed ID: 24107468
[TBL] [Abstract][Full Text] [Related]
20. TIMP-1 overexpression does not affect sensitivity to HER2-targeting drugs in the HER2-gene-amplified SK-BR-3 human breast cancer cell line.
Deng X; Fogh L; Lademann U; Jensen V; Stenvang J; Yang H; Brünner N; Schrohl AS
Tumour Biol; 2013 Apr; 34(2):1161-70. PubMed ID: 23334956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
